- Home
- GNSS vs VSTM Comparison
GNSS vs VSTM Comparison
Compare GNSS & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- VSTM
- Stock Information
- Founded
- GNSS 1992
- VSTM 2010
- Country
- GNSS United States
- VSTM United States
- Employees
- GNSS N/A
- VSTM N/A
- Industry
- GNSS Consumer Electronics/Appliances
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- VSTM Health Care
- Exchange
- GNSS Nasdaq
- VSTM Nasdaq
- Market Cap
- GNSS 98.9M
- VSTM 425.9M
- IPO Year
- GNSS N/A
- VSTM 2012
- Fundamental
- Price
- GNSS $1.77
- VSTM $4.89
- Analyst Decision
- GNSS Strong Buy
- VSTM Strong Buy
- Analyst Count
- GNSS 3
- VSTM 9
- Target Price
- GNSS $5.33
- VSTM $12.63
- AVG Volume (30 Days)
- GNSS 117.0K
- VSTM 2.5M
- Earning Date
- GNSS 08-05-2025
- VSTM 08-07-2025
- Dividend Yield
- GNSS N/A
- VSTM N/A
- EPS Growth
- GNSS N/A
- VSTM N/A
- EPS
- GNSS N/A
- VSTM N/A
- Revenue
- GNSS $27,780,000.00
- VSTM $10,000,000.00
- Revenue This Year
- GNSS $91.14
- VSTM $129.06
- Revenue Next Year
- GNSS $75.44
- VSTM $306.32
- P/E Ratio
- GNSS N/A
- VSTM N/A
- Revenue Growth
- GNSS N/A
- VSTM N/A
- 52 Week Low
- GNSS $1.46
- VSTM $2.10
- 52 Week High
- GNSS $4.04
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- GNSS 57.13
- VSTM 39.79
- Support Level
- GNSS $1.48
- VSTM $4.01
- Resistance Level
- GNSS $1.85
- VSTM $5.06
- Average True Range (ATR)
- GNSS 0.09
- VSTM 0.35
- MACD
- GNSS 0.04
- VSTM 0.01
- Stochastic Oscillator
- GNSS 79.49
- VSTM 43.17
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.